| 标题 |
Health-related quality of life (HRQL) assessments in a 52-week, double-blind, randomized, placebo-controlled phase III study of resmetirom (MGL-3196) in patients with metabolic dysfunction–associated steatohepatitis (MASH) and fibrosis |
| 网址 | |
| DOI |
10.1097/HEP.0000000000001084
doi
|
| 其它 |
期刊:Hepatology 作者:Zobair M. Younossi; Maria Stepanova; Andrei Racila; Linda Henry; Dominic Labriola; et al 出版日期:2024-09-06 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)